Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.261
+0.011 (0.85%)
May 27, 2025, 1:52 PM - Market open
Mustang Bio Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Mustang Bio.
Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Mustang Bio.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +7,832.73% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1,250 → $100 | Strong Buy | Maintains | $1,250 → $100 | +7,832.73% | May 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $900 | Buy | Reiterates | $900 | +71,294.57% | Aug 24, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $1,250 | Strong Buy | Reiterates | $1,250 | +99,059.13% | Aug 16, 2023 |
| BTIG | BTIG | Strong Buy Maintains $1,000 → $800 | Strong Buy | Maintains | $1,000 → $800 | +63,361.84% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-17.85
from -25.84
EPS Next Year
n/a
from -17.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 |
|---|---|
| High | n/a |
| Avg | n/a |
| Low | n/a |
Revenue Growth
| Revenue Growth | 2025 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS | 2025 |
|---|---|
| High | -18.38 |
| Avg | -17.85 |
| Low | -17.15 |
EPS Growth
| EPS Growth | 2025 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.